AAAAAA

   
Results: 1-25 | 26-50 | 51-75
Results: 26-50/75
LONG-TERM FOLLOW-UP OF THE ITALIAN TRIAL OF INTERFERON-ALPHA VERSUS CONVENTIONAL CHEMOTHERAPY IN CHRONIC MYELOID-LEUKEMIA
Authors: TURA S ROSTI G DEVIVO A BONIFAZI F FIACCHINI M BACCARANI M RUSSO D FANIN R ZUFFA E MONTEFUSCO E
Citation: S. Tura et al., LONG-TERM FOLLOW-UP OF THE ITALIAN TRIAL OF INTERFERON-ALPHA VERSUS CONVENTIONAL CHEMOTHERAPY IN CHRONIC MYELOID-LEUKEMIA, Blood, 92(5), 1998, pp. 1541-1548
1070 MYELOABLATIVE MEGATHERAPY PROCEDURES FOLLOWED BY STEM-CELL RESCUE FOR NEUROBLASTOMA - 17 YEARS OF EUROPEAN EXPERIENCE AND CONCLUSIONS
Authors: PHILIP T LADENSTEIN R LASSET C HARTMANN O ZUCKER JM PINKERTON R PEARSON ADJ KLINGEBIEL T GARAVENTA A KREMENS B BERNARD JL ROSTI G CHAUVIN F
Citation: T. Philip et al., 1070 MYELOABLATIVE MEGATHERAPY PROCEDURES FOLLOWED BY STEM-CELL RESCUE FOR NEUROBLASTOMA - 17 YEARS OF EUROPEAN EXPERIENCE AND CONCLUSIONS, European journal of cancer, 33(12), 1997, pp. 2130-2135
RESPONSE TO SEQUENTIAL TREATMENT WITH LYMPHOBLASTOID INTERFERON-ALPHAIN PATIENTS WITH PH-LEUKEMIA UNRESPONSIVE TO RECOMBINANT INTERFERON-ALPHA (RIFN-ALPHA-2A) AND NEUTRALIZING-RIFN-ALPHA-2A ANTIBODIES NEGATIVE( CHRONIC MYELOID)
Authors: RUSSO D CANDONI A GRATTONI R MINISINI R ROSTI G
Citation: D. Russo et al., RESPONSE TO SEQUENTIAL TREATMENT WITH LYMPHOBLASTOID INTERFERON-ALPHAIN PATIENTS WITH PH-LEUKEMIA UNRESPONSIVE TO RECOMBINANT INTERFERON-ALPHA (RIFN-ALPHA-2A) AND NEUTRALIZING-RIFN-ALPHA-2A ANTIBODIES NEGATIVE( CHRONIC MYELOID), Haematologica, 82(3), 1997, pp. 348-350
THE USE OF GRANULOCYTE-COLONY-STIMULATING FACTORS FOLLOWING PERIPHERAL-BLOOD PROGENITOR-CELL RESCUE AFTER HIGH-DOSE CHEMOTHERAPY FOR ADVANCED BREAST-CANCER - A PROSPECTIVE-STUDY
Authors: DAZZI C ALBERTAZZI L ROSTI G MAESTRI A FIORENTINI G LEONI M TIENGHI A TURCI D FERRANTE P VERTOGEN B CARIELLO A LATINO W ZUMAGLINI F MARANGOLO M
Citation: C. Dazzi et al., THE USE OF GRANULOCYTE-COLONY-STIMULATING FACTORS FOLLOWING PERIPHERAL-BLOOD PROGENITOR-CELL RESCUE AFTER HIGH-DOSE CHEMOTHERAPY FOR ADVANCED BREAST-CANCER - A PROSPECTIVE-STUDY, Tumori, 83(6), 1997, pp. 900-903
SALVAGE CHEMOTHERAPY FOR RECURRENT INVASIVE THYMOMA
Authors: MUSI M DIVITO F ROSTI G
Citation: M. Musi et al., SALVAGE CHEMOTHERAPY FOR RECURRENT INVASIVE THYMOMA, Chest, 112(2), 1997, pp. 572-573
QUANTITATIVE PCR DISTINGUISHES PATIENTS IN COMPLETE KARYOTYPIC CONVERSION FROM PATIENTS IN MAJOR KARYOTYPIC CONVERSION
Authors: MARTINELLI G TESTONI N AMABILE M BONIFAZI F FARABEGOLI P TERRAGNA C MONTEFUSCO V SAGLIO G ROSTI G RUSSO D BACCARANI M TURA S
Citation: G. Martinelli et al., QUANTITATIVE PCR DISTINGUISHES PATIENTS IN COMPLETE KARYOTYPIC CONVERSION FROM PATIENTS IN MAJOR KARYOTYPIC CONVERSION, Blood, 90(10), 1997, pp. 4004-4004
DEPRESSIVE SYMPTOMS IN AUTOLOGOUS BONE-MARROW TRANSPLANT (ABMT) PATIENTS WITH CANCER - AN EXPLORATORY-STUDY
Authors: GRASSI L ROSTI G ALBERTAZZI L MARANGOLO M
Citation: L. Grassi et al., DEPRESSIVE SYMPTOMS IN AUTOLOGOUS BONE-MARROW TRANSPLANT (ABMT) PATIENTS WITH CANCER - AN EXPLORATORY-STUDY, Psycho-oncology, 5(4), 1996, pp. 305-310
FINGERPRINTING OF HLA CLASS-I GENES FOR IMPROVED SELECTION OF UNRELATED BONE-MARROW DONORS
Authors: MARTINELLI G FARABEGOLI P BUZZI M PANZICA G ZACCARIA A BANDINI G CALORI E TESTONI N ROSTI G CONTE R REMIDDI C SALVUCCI M DEVIVO A TURA S
Citation: G. Martinelli et al., FINGERPRINTING OF HLA CLASS-I GENES FOR IMPROVED SELECTION OF UNRELATED BONE-MARROW DONORS, European journal of immunogenetics, 23(1), 1996, pp. 55-65
AUTOLOGOUS BONE-MARROW TRANSPLANTATION IN LATE FIRST COMPLETE REMISSION IMPROVES OUTCOME IN ACUTE MYELOGENOUS LEUKEMIA
Authors: MIGGIANO MC GHERLINZONI F ROSTI G BANDINI G VISANI G FIACCHINI M RICCI P TESTONI N MOTTA MR GEROMIN A RIZZI S BELARDINELLI A MANGIANTI S MANFROI S TURA S
Citation: Mc. Miggiano et al., AUTOLOGOUS BONE-MARROW TRANSPLANTATION IN LATE FIRST COMPLETE REMISSION IMPROVES OUTCOME IN ACUTE MYELOGENOUS LEUKEMIA, Leukemia, 10(3), 1996, pp. 402-409
CONCOMITANT AND SEQUENTIAL ADMINISTRATION OF RECOMBINANT HUMAN GRANULOCYTE-COLONY-STIMULATING FACTOR AND RECOMBINANT HUMAN INTERLEUKIN-3 TOACCELERATE HEMATOPOIETIC RECOVERY AFTER AUTOLOGOUS BONE-MARROW TRANSPLANTATION FOR MALIGNANT-LYMPHOMA
Authors: LEMOLI RM ROSTI G VISANI G GHERLINZONI F MIGGIANO MC FORTUNA A ZINZANI P TURA S
Citation: Rm. Lemoli et al., CONCOMITANT AND SEQUENTIAL ADMINISTRATION OF RECOMBINANT HUMAN GRANULOCYTE-COLONY-STIMULATING FACTOR AND RECOMBINANT HUMAN INTERLEUKIN-3 TOACCELERATE HEMATOPOIETIC RECOVERY AFTER AUTOLOGOUS BONE-MARROW TRANSPLANTATION FOR MALIGNANT-LYMPHOMA, Journal of clinical oncology, 14(11), 1996, pp. 3018-3025
PHASE-II STUDY OF INTENSIVE CHEMOTHERAPY WITH CARBOPLATIN, IFOSFAMIDEAND ETOPOSIDE PLUS RECOMBINANT HUMAN GRANULOCYTE-COLONY-STIMULATING FACTOR AND SEQUENTIAL RADIOTHERAPY IN LOCALLY ADVANCED, UNRESECTABLE NON-SMALL-CELL LUNG-CANCER
Authors: SCAGLIOTTI GV RICARDI U CRINO L MARANZANO E DEMARINIS F MORANDI MG EMILIANI E ROSTI G FIGOLI F BOLZICCO G MASIERO P GENTILE A TONATO M
Citation: Gv. Scagliotti et al., PHASE-II STUDY OF INTENSIVE CHEMOTHERAPY WITH CARBOPLATIN, IFOSFAMIDEAND ETOPOSIDE PLUS RECOMBINANT HUMAN GRANULOCYTE-COLONY-STIMULATING FACTOR AND SEQUENTIAL RADIOTHERAPY IN LOCALLY ADVANCED, UNRESECTABLE NON-SMALL-CELL LUNG-CANCER, Cancer chemotherapy and pharmacology, 38(6), 1996, pp. 561-565
BLOOD AND MARROW STEM-CELL TRANSPLANTS IN EUROPE
Authors: GRATWOHL A HERMANS J SCHMITZ N GORIN NC APPERLEY J GOLDSTONE AH ROSTI G GAHRTON G BACIGALUPO A
Citation: A. Gratwohl et al., BLOOD AND MARROW STEM-CELL TRANSPLANTS IN EUROPE, Experimental hematology, 24(9), 1996, pp. 656-656
ALPHA-IFN TREATMENT OF CML - CLINIC, CYTOGENETIC AND MOLECULAR UPDATE
Authors: ZACCARIA A ZUFFA E ROSTI G BACCARANI M TURA S
Citation: A. Zaccaria et al., ALPHA-IFN TREATMENT OF CML - CLINIC, CYTOGENETIC AND MOLECULAR UPDATE, Experimental hematology, 24(9), 1996, pp. 719-719
HIGH-DOSE CHEMOTHERAPY AND PERIPHERAL-BLO OD PROGENITOR CELLS WITH RESPECT TO SOLID TUMORS
Authors: ROSTI G FERRANTE P TIENGHI A TURCI D DAZZI C LEONI M FIORENTINI G FERRARI E ZORNETTA L MARANGOLO M
Citation: G. Rosti et al., HIGH-DOSE CHEMOTHERAPY AND PERIPHERAL-BLO OD PROGENITOR CELLS WITH RESPECT TO SOLID TUMORS, Tumori, 82(2), 1996, pp. 19-22
THE UROPEAN-GROUP-FOR-BLOOD-AND-MARROW-TRANSPLANTATION (EBMT) - A REPORT FROM THE PRESIDENT AND THE CHAIRMEN OF THE WORKING PARTIES
Authors: GRATWOHL A GORIN C APPERLEY J GOLDSTONE A ROSTI G BACIGALUPO A GLUCKMAN E FISCHER A LJUNGMAN P KOLB HJ NIETHAMMER D
Citation: A. Gratwohl et al., THE UROPEAN-GROUP-FOR-BLOOD-AND-MARROW-TRANSPLANTATION (EBMT) - A REPORT FROM THE PRESIDENT AND THE CHAIRMEN OF THE WORKING PARTIES, Bone marrow transplantation, 18(4), 1996, pp. 677-691
INCREASED PLASMA-LEVEL OF VASCULAR ENDOTHELIAL GLYCOPROTEIN THROMBOMODULIN AS AN EARLY INDICATOR OF ENDOTHELIAL DAMAGE IN BONE-MARROW TRANSPLANTATION
Authors: TESTA S MANNA A PORCELLINI A MAFFI F MORSTABILINI G DENTI N MACCHI S ROSTI G PORCELLINI G CASSI D FERRARI L
Citation: S. Testa et al., INCREASED PLASMA-LEVEL OF VASCULAR ENDOTHELIAL GLYCOPROTEIN THROMBOMODULIN AS AN EARLY INDICATOR OF ENDOTHELIAL DAMAGE IN BONE-MARROW TRANSPLANTATION, Bone marrow transplantation, 18(2), 1996, pp. 383-388
IMMUNOLOGICAL AND CLINICAL MODIFICATIONS FOLLOWING LOW-DOSE SUBCUTANEOUS ADMINISTRATION OF RIL-2 IN NON-HODGKINS-LYMPHOMA PATIENTS AFTER AUTOLOGOUS BONE-MARROW TRANSPLANTATION
Authors: LAURIA F RASPADORI D VENTURA MA RONDELLI D ZINZANI PL GHERLINZONI F MIGGIANO MC FIACCHINI M ROSTI G RIZZI S TURA S
Citation: F. Lauria et al., IMMUNOLOGICAL AND CLINICAL MODIFICATIONS FOLLOWING LOW-DOSE SUBCUTANEOUS ADMINISTRATION OF RIL-2 IN NON-HODGKINS-LYMPHOMA PATIENTS AFTER AUTOLOGOUS BONE-MARROW TRANSPLANTATION, Bone marrow transplantation, 18(1), 1996, pp. 79-85
PSYCHOLOGICAL STRESS SYMPTOMS BEFORE AND AFTER AUTOLOGOUS BONE-MARROWTRANSPLANTATION IN PATIENTS WITH SOLID TUMORS
Authors: GRASSI L ROSTI G ALBERTAZZI L MARANGOLO M
Citation: L. Grassi et al., PSYCHOLOGICAL STRESS SYMPTOMS BEFORE AND AFTER AUTOLOGOUS BONE-MARROWTRANSPLANTATION IN PATIENTS WITH SOLID TUMORS, Bone marrow transplantation, 17(5), 1996, pp. 843-847
INTERFERON-ALPHA IN THE TREATMENT OF CHRONIC MYELOID-LEUKEMIA - A SUMMARY AND AN UPDATE OF THE ITALIAN STUDIES
Authors: ROSTI G DEVIVO A ZUFFA E BACCARANI M
Citation: G. Rosti et al., INTERFERON-ALPHA IN THE TREATMENT OF CHRONIC MYELOID-LEUKEMIA - A SUMMARY AND AN UPDATE OF THE ITALIAN STUDIES, Bone marrow transplantation, 17, 1996, pp. 11-13
UNRELATED DONOR MARROW TRANSPLANTATION - INITIAL EXPERIENCE OF THE ITALIAN BONE-MARROW TRANSPLANT GROUP (GITMO)
Authors: DINI G LANINO E LAMPARELLI T BARBANTI M SACCHI N CARCASSI C LOCATELLI F PORTA F ROSTI G ALESSANDRINO EP AVERSA F MARENCO P GUIDI S UDERZO C AMOROSO A DIBARTOLOMEO P GARBARINO L LANASA G ROSSETTI F MINIERO R SOLIGO D MANFREDINI L BACIGALUPO A
Citation: G. Dini et al., UNRELATED DONOR MARROW TRANSPLANTATION - INITIAL EXPERIENCE OF THE ITALIAN BONE-MARROW TRANSPLANT GROUP (GITMO), Bone marrow transplantation, 17(1), 1996, pp. 55-62
ITRACONAZOLE CAN INCREASE SYSTEMIC EXPOSURE TO BUSULFAN IN PATIENTS GIVEN BONE-MARROW TRANSPLANTATION
Authors: BUGGIA I ZECCA M ALESSANDRINO EP LOCATELLI F ROSTI G BOSI A PESSION A ROTOLI B MAJOLINO I DALLORSO A REGAZZI MB
Citation: I. Buggia et al., ITRACONAZOLE CAN INCREASE SYSTEMIC EXPOSURE TO BUSULFAN IN PATIENTS GIVEN BONE-MARROW TRANSPLANTATION, Anticancer research, 16(4A), 1996, pp. 2083-2088
PHASE I II STUDY OF PACLITAXEL AND RADIOTHERAPY IN NONSMALL CELL LUNG-CANCER/
Authors: MARANGOLO M EMILIANI E ROSTI G GIANNINI M VERTOGEN B ZUMAGLINI F
Citation: M. Marangolo et al., PHASE I II STUDY OF PACLITAXEL AND RADIOTHERAPY IN NONSMALL CELL LUNG-CANCER/, Seminars in oncology, 23(6), 1996, pp. 124-127
PACLITAXEL AND RADIOTHERAPY IN THE TREATMENT OF ADVANCED NONSMALL CELL LUNG-CANCER
Authors: MARANGOLO M EMILIANI E ROSTI G GIANNINI M VERTOGEN B ZUMAGLINI F
Citation: M. Marangolo et al., PACLITAXEL AND RADIOTHERAPY IN THE TREATMENT OF ADVANCED NONSMALL CELL LUNG-CANCER, Seminars in oncology, 23(6), 1996, pp. 31-34
PSYCHIATRIC AND PSYCHOSOCIAL CONCOMITANTS OF ABNORMAL ILLNESS BEHAVIOR IN PATIENTS WITH CANCER
Authors: GRASSI L ROSTI G
Citation: L. Grassi et G. Rosti, PSYCHIATRIC AND PSYCHOSOCIAL CONCOMITANTS OF ABNORMAL ILLNESS BEHAVIOR IN PATIENTS WITH CANCER, Psychotherapy and psychosomatics, 65(5), 1996, pp. 246-252
PSYCHOSOCIAL MORBIDITY AND ADJUSTMENT TO ILLNESS AMONG LONG-TERM CANCER SURVIVORS - A 6-YEAR FOLLOW-UP-STUDY
Authors: GRASSI L ROSTI G
Citation: L. Grassi et G. Rosti, PSYCHOSOCIAL MORBIDITY AND ADJUSTMENT TO ILLNESS AMONG LONG-TERM CANCER SURVIVORS - A 6-YEAR FOLLOW-UP-STUDY, Psychosomatics, 37(6), 1996, pp. 523-532
Risultati: 1-25 | 26-50 | 51-75